diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
Hyperosmolar hyperglycemic state in pediatric patients has blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state Management

Monitoring

Adult diabetic ketoacidosis (DKA)

  • Check glucose, blood urea nitrogen (BUN), creatinine, & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

Criteria for Resolution of DKA:

  • Blood glucose <200 mg/dL
  • Venous pH >7.3
  • Bicarbonate ≥15 mEq/L

After Resolution of DKA:

  • If patient is nothing by mouth/non per os (NPO), continue intravenous (IV) insulin & supplement w/ Regular insulin subcutaneous (SC) as required every 4 hours

Once patient is able to eat:

  • Start multidose insulin regimen & adjust as required
  • IV insulin should be continued for 1-2 hours after SC insulin is started

Adult hyperosmolar hyperglycemic state (HHS)

  • Check BUN, creatinine, electrolytes, & glucose every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of HHS:

  • If patient is NPO continue IV insulin & supplement w/ SC insulin as required

Once patient is able to eat:

  • Start multidose insulin regimen (such as SC), or give as previous treatment & check metabolic control

Pediatric DKA & HHS

  • Check glucose & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of DKA:

  • Start SC insulin (0.5-1 U/kg/day)
    • Give 2/3 of the total daily dose in the AM (1/3 short-acting & 2/3 of dose intermediate-acting insulin)
    • Give 1/3 of total daily dose in the PM (1/2 short-acting & 1/2 of dose intermediate-acting insulin)
  • Or give 0.1-0.25 U/kg SC of Regular insulin every 6-8 hours for the first 24 hours to determine insulin requirements
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.